Literature DB >> 18379238

Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure?

Andrea Lassnigg1, Edith R Schmid, Michael Hiesmayr, Christian Falk, Wilfred Druml, Peter Bauer, Daniel Schmidlin.   

Abstract

OBJECTIVE: Traditional cutoff values of serum creatinine considered to define postoperative acute renal failure have been challenged recently. In a previous investigation we demonstrated that minimal changes in serum creatinine concentration were associated with a substantial decrease in survival after cardiac surgery. In this investigation, we assessed the impact of minimal absolute increases in serum creatinine in a second institution, and we analyzed whether relative changes, as in the RIFLE classification and, partially, in Acute Kidney Injury Network (AKIN) classification, confer a different prognostic potential.
DESIGN: Prospective analysis.
SETTING: University hospital. PATIENTS: All consecutive patients undergoing cardiac surgery in the University Hospital of Zurich (Center USZ) over a 46-month period.
INTERVENTIONS: Patients were prospectively documented. We analyzed maximal changes in serum creatinine in the first 48 hrs postoperatively (DeltaCrea) regarding death within 30 days. Results were compared with those of the University Hospital Vienna (Center AKH). Moreover, the prognostic potential of DeltaCrea within 48 hrs vs. serum creatinine elements according to RIFLE and AKIN classifications was assessed.
MEASUREMENTS AND MAIN RESULTS: A total of 3,123 patients were evaluated from USZ. The majority of patients had decreased postoperative serum creatinine values (negative DeltaCrea) and the lowest mortality (1.8%). Minimal increases, [0, 0.5) mg x dL(-1), were associated with a more than doubled mortality in both centers (5%/6%). Mortality, according to RIFLE and AKIN classifications for both populations combined, was as follows: 7,023 (3.6%), 160 (29%), 43 (19%), and 15 (33%) for RIFLE Normal, Risk, Injury, and Failure; 6,644 (2.8), 463 (16.4), 3 (66.7), and 131 (1.8) for AKIN stage 0, 1, 2, and 3.
CONCLUSIONS: Measuring repeat serum creatinine concentrations within 48 hrs and determining DeltaCrea were the most effective discrimination method to find patients at risk for adverse postoperative outcome after cardiac surgery, better than application of this sole criterion to the RIFLE (least discriminatory) or the AKIN classification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379238     DOI: 10.1097/CCM.0b013e318169181a

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  83 in total

1.  The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.

Authors:  Michael Haase; Prasad Devarajan; Anja Haase-Fielitz; Rinaldo Bellomo; Dinna N Cruz; Gebhard Wagener; Catherine D Krawczeski; Jay L Koyner; Patrick Murray; Michael Zappitelli; Stuart L Goldstein; Konstantinos Makris; Claudio Ronco; Johan Martensson; Claes-Roland Martling; Per Venge; Edward Siew; Lorraine B Ware; T Alp Ikizler; Peter R Mertens
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

2.  Same admission cardiac catheterization and cardiac surgery: is there an increased incidence of acute kidney injury?

Authors:  Robert S Kramer; Reed D Quinn; Robert C Groom; John H Braxton; David J Malenka; Mirle A Kellett; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

3.  A multicenter international survey of renal supportive therapy during ECMO: the Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) group.

Authors:  Geoffrey M Fleming; David J Askenazi; Brian C Bridges; David S Cooper; Mathew L Paden; David T Selewski; Michael Zappitelli
Journal:  ASAIO J       Date:  2012 Jul-Aug       Impact factor: 2.872

4.  Approaches to the Management of Acute Kidney Injury in Children.

Authors:  Rajit K Basu; Derek S Wheeler
Journal:  Recent Pat Biomark       Date:  2011

5.  Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium.

Authors:  D Hori; C Brown; M Ono; T Rappold; F Sieber; A Gottschalk; K J Neufeld; R Gottesman; H Adachi; C W Hogue
Journal:  Br J Anaesth       Date:  2014-09-25       Impact factor: 9.166

6.  Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients.

Authors:  Tjörvi E Perry; Jochen D Muehlschlegel; Kuang-Yu Liu; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Anesth Analg       Date:  2010-04-30       Impact factor: 5.108

7.  The Incidence of Acute Kidney Injury and Its Effect on Neonatal and Pediatric Extracorporeal Membrane Oxygenation Outcomes: A Multicenter Report From the Kidney Intervention During Extracorporeal Membrane Oxygenation Study Group.

Authors:  Geoffrey M Fleming; Rashmi Sahay; Michael Zappitelli; Eileen King; David J Askenazi; Brian C Bridges; Matthew L Paden; David T Selewski; David S Cooper
Journal:  Pediatr Crit Care Med       Date:  2016-12       Impact factor: 3.624

8.  Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.

Authors:  David R McIlroy; Gebhard Wagener; H Thomas Lee
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

9.  Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients.

Authors:  Felix Kork; Felix Balzer; Claudia D Spies; Klaus-Dieter Wernecke; Adit A Ginde; Joachim Jankowski; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

Review 10.  Clinical review: RIFLE and AKIN--time for reappraisal.

Authors:  Dinna N Cruz; Zaccaria Ricci; Claudio Ronco
Journal:  Crit Care       Date:  2009-06-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.